Walleye Capital LLC

Position in NVAX — Novavax Inc

CIK 1758720 NEW YORK, NY

Back to NVAX Full portfolio

Position in NVAX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$156,174

-$152,494 QoQ

Shares Held

16,579

-56.3% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#142

of 263 holders

Holding Since

Mar 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Jun 30, 2026

CallValue

$87,606

CallShares

9,300

PutValue

$105,504

PutShares

11,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,313,978 across 124 Biotechnology names. NVAX ranks #95 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	126,005	$33,608,053
2	CYTK	Cytokinetics Inc	239,728	$20,422,428
3	BMRN	Biomarin Pharmaceutical Inc	288,233	$16,492,692
4	IDYA	IDEAYA Biosciences, Inc.	386,183	$14,393,040
5	REGN	Regeneron Pharmaceuticals, Inc.	22,596	$14,089,509
6	RARE	Ultragenyx Pharmaceutical Inc.	334,854	$11,180,775
7	TYRA	Tyra Biosciences, Inc.	347,898	$11,111,862
8	BCAX	Bicara Therapeutics Inc.	353,226	$10,487,279

All Filings in NVAX

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$87,606	9,300	+3000.0%	Call	Sole	2026-08-03
2026-06-30	$105,504	11,200	-74.1%	Put	Sole	2026-08-03
2026-06-30	$156,174	16,579	-56.3%	Shares	Sole	2026-08-03
2026-03-31	$2,442	300	-98.7%	Call	Sole	2026-05-13
2026-03-31	$308,668	37,920	-57.7%	Shares	Sole	2026-05-13
2026-03-31	$351,648	43,200	-56.8%	Put	Sole	2026-05-13
2025-12-31	$150,528	22,400	-84.8%	Call	Sole	2026-02-13
2025-12-31	$601,836	89,559	+587.1%	Shares	Sole	2026-02-13
2025-12-31	$671,328	99,900	-34.5%	Put	Sole	2026-02-13
2025-09-30	$1,276,224	147,200	+1.2%	Call	Sole	2025-11-14
2025-09-30	$1,322,175	152,500	+26.8%	Put	Sole	2025-11-14
2025-09-30	$113,004	13,034	-70.5%	Shares	Sole	2025-11-14
2025-06-30	$278,415	44,193	+140.1%	Shares	Sole	2025-08-13
2025-06-30	$916,020	145,400	+196.7%	Call	Sole	2025-08-13
2025-06-30	$757,890	120,300	+536.5%	Put	Sole	2025-08-13
2025-03-31	$121,149	18,900	-52.2%	Put	Sole	2025-05-14
2025-03-31	$314,090	49,000	+57.1%	Call	Sole	2025-05-14
2025-03-31	$117,963	18,403	-40.1%	Shares	Sole	2025-05-14
2024-12-31	$246,908	30,710	-48.8%	Shares	Sole	2025-02-13
2024-12-31	$317,580	39,500	-13.9%	Put	Sole	2025-02-13
2024-12-31	$250,848	31,200	+50.0%	Call	Sole	2025-02-13
2024-09-30	$579,717	45,900	-59.5%	Put	Sole	2024-11-14
2024-09-30	$757,408	59,969	-84.8%	Shares	Sole	2024-11-14
2024-09-30	$262,704	20,800	-70.1%	Call	Sole	2024-11-14
2024-06-30	$879,870	69,500	+1554.8%	Call	Sole	2024-08-14
2024-06-30	$1,433,112	113,200	+812.9%	Put	Sole	2024-08-14
2024-06-30	$4,986,989	393,917	+20830.8%	Shares	Sole	2024-08-14
2024-03-31	$59,272	12,400	+2.5%	Put	Sole	2024-05-15
2024-03-31	$8,995	1,882	-96.7%	Shares	Sole	2024-05-15
2024-03-31	$20,076	4,200	-55.8%	Call	Sole	2024-05-15
2023-06-30	$89,903	12,100	-18.2%	Put	Sole	2023-08-14
2023-06-30	$418,182	56,283	-48.6%	Shares	Sole	2023-08-14
2023-06-30	$70,585	9,500	-59.7%	Call	Sole	2023-08-14
2023-03-31	$163,548	23,600	+10.3%	Call	Sole	2023-05-15
2023-03-31	$102,564	14,800	-29.2%	Put	Sole	2023-05-15
2022-12-31	$1,126,030	109,536	+45.7%	Shares	Sole	2023-02-14
2022-12-31	$219,992	21,400	-18.9%	Call	Sole	2023-02-14
2022-12-31	$214,852	20,900	-45.7%	Put	Sole	2023-02-14
2022-09-30	$480,480	26,400	—	Call	Sole	2022-11-14
2022-09-30	$700,700	38,500	—	Put	Sole	2022-11-14
2022-09-30	$1,368,658	75,201	+632.0%	Shares	Sole	2022-11-14
2022-03-31	$756,606	10,273	—	Shares	Sole	2022-05-27
No filing history on record for this holder in this stock.